Zelong Lin

509 total citations
13 papers, 268 citations indexed

About

Zelong Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zelong Lin has authored 13 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Zelong Lin's work include MicroRNA in disease regulation (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Inflammasome and immune disorders (2 papers). Zelong Lin is often cited by papers focused on MicroRNA in disease regulation (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Inflammasome and immune disorders (2 papers). Zelong Lin collaborates with scholars based in China, United States and Thailand. Zelong Lin's co-authors include Weiyi Fang, Xian Lin, Chen Qu, Hui Yuan, Mengxian Tu, Jian Hong, Yaoliang Tang, Ziqing Wu, Yanjuan Chen and Yujiao Zou and has published in prestigious journals such as American Journal Of Pathology, Journal of Ethnopharmacology and Advanced Science.

In The Last Decade

Zelong Lin

12 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zelong Lin China	8	163	106	63	39	33	13	268
Stefania Pieroni Italy	11	194 1.2×	74 0.7×	70 1.1×	32 0.8×	32 1.0×	21	284
Zhangwei Tong China	9	235 1.4×	106 1.0×	90 1.4×	41 1.1×	30 0.9×	17	347
Shufeng Ji China	11	172 1.1×	125 1.2×	79 1.3×	35 0.9×	21 0.6×	17	301
Qiandong Zhu China	10	212 1.3×	168 1.6×	53 0.8×	25 0.6×	40 1.2×	14	309
Long Feng China	11	220 1.3×	136 1.3×	76 1.2×	59 1.5×	36 1.1×	44	360
Mujian Teng China	10	227 1.4×	164 1.5×	62 1.0×	43 1.1×	30 0.9×	11	335
Feiye Liu China	9	213 1.3×	148 1.4×	44 0.7×	19 0.5×	18 0.5×	13	294
Haitao Zhang China	11	221 1.4×	172 1.6×	53 0.8×	25 0.6×	23 0.7×	25	340
Atsutaka Masuda Japan	9	142 0.9×	92 0.9×	85 1.3×	27 0.7×	24 0.7×	19	279
Yaozhen Pan China	7	176 1.1×	92 0.9×	91 1.4×	46 1.2×	26 0.8×	22	284

Countries citing papers authored by Zelong Lin

Since Specialization

Citations

This map shows the geographic impact of Zelong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelong Lin more than expected).

Fields of papers citing papers by Zelong Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelong Lin. The network helps show where Zelong Lin may publish in the future.

Co-authorship network of co-authors of Zelong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zelong Lin. A scholar is included among the top collaborators of Zelong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelong Lin. Zelong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

An, Chenrui, Xiangjin Kang, Yingying Zhang, et al.. (2025). H3K27ac Is Essential for Human Naive Pluripotency Modulated by m6A‐Driven EP300 Expression. Advanced Science. 12(41). e07549–e07549.

Sun, Yuan, et al.. (2025). Sanqi qushi formula ameliorates podocyte injury in membranous nephropathy by inhibiting endoplasmic reticulum stress-induced ferroptosis. Journal of Ethnopharmacology. 353(Pt B). 120453–120453. 1 indexed citations

Lin, Zelong, Jun Wang, Shilong Yang, et al.. (2025). Changdiqing decoction (CDQD) ameliorates colitis via suppressing inflammatory macrophage activation and modulating gut microbiota. Phytomedicine. 143. 156856–156856. 2 indexed citations

Wang, Jun, Huishi Tan, Z. Ye, et al.. (2025). Gut microbial Nordihydroguaiaretic acid suppresses macrophage pyroptosis to regulate epithelial homeostasis and inflammation. Gut Microbes. 17(1). 2518338–2518338. 1 indexed citations

Lin, Zelong, Lei Chen, Shilong Yang, et al.. (2024). Wogonin mitigates acetaminophen-induced liver injury in mice through inhibition of the PI3K/AKT signaling pathway. Journal of Ethnopharmacology. 332. 118364–118364. 8 indexed citations

Xie, Binhui, Rong Ye, Jinrong Zhu, et al.. (2023). Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells. Oncogenesis. 12(1). 13–13. 9 indexed citations

Lin, Zelong, et al.. (2021). circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1. Experimental and Therapeutic Medicine. 22(3). 934–934. 16 indexed citations

Lin, Zelong, et al.. (2020). ARRB2 promotes colorectal cancer growth through triggering WTAP. Acta Biochimica et Biophysica Sinica. 53(1). 85–93. 16 indexed citations

Yuan, Hui, Zelong Lin, Yingjun Liu, et al.. (2020). Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness. Cancer Cell International. 20(1). 586–586. 46 indexed citations

10.

Zheng, Dandan, Yuchuan Jiang, Chen Qu, et al.. (2020). Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis. American Journal Of Pathology. 190(11). 2267–2281. 50 indexed citations

11.

Zou, Yujiao, Xian Lin, Junguo Bu, et al.. (2019). Timeless-Stimulated miR-5188-FOXO1/β-Catenin-c-Jun Feedback Loop Promotes Stemness via Ubiquitination of β-Catenin in Breast Cancer. Molecular Therapy. 28(1). 313–327. 58 indexed citations

12.

Liu, Xiong, Xian Lin, Yanyi Xiao, et al.. (2019). Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9. Signal Transduction and Targeted Therapy. 4(1). 48–48. 60 indexed citations

13.

Lin, Zelong, et al.. (2019). Research on Media Literacy Cultivation Strategies of Chinese College Students in the "Post-Truth Age". International Journal of Social Science Studies. 7(6). 35–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact